PFE Pfizer Inc
Price (delayed)
$24.54
Market cap
$139.08B
P/E Ratio
17.28
Dividend/share
$1.69
EPS
$1.42
Enterprise value
$202.38B
Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United
Highlights
Pfizer's net income has surged by 89% QoQ
Pfizer's EPS has soared by 87% from the previous quarter
Pfizer's equity has decreased by 4.4% QoQ
Key stats
What are the main financial stats of PFE
Market
Valuations
Earnings
Shares outstanding
5.67B
Market cap
$139.08B
Enterprise value
$202.38B
Price to earnings (P/E)
17.28
Price to book (P/B)
1.58
Price to sales (P/S)
2.18
EV/EBIT
25.29
EV/EBITDA
13.48
EV/Sales
3.18
Revenue
$63.63B
Gross profit
$45.78B
Operating income
$8.02B
Net income
$8.03B
EBIT
$8B
EBITDA
$15.02B
Free cash flow
$9.84B
Per share
Balance sheet
Liquidity
EPS
$1.42
EPS diluted
$1.41
Free cash flow per share
$1.74
Book value per share
$15.56
Revenue per share
$11.23
TBVPS
$15.79
Total assets
$213.4B
Total liabilities
$124.9B
Debt
$64.35B
Equity
$88.2B
Working capital
$7.36B
Debt to equity
0.73
Current ratio
1.17
Quick ratio
0.74
Net debt/EBITDA
4.22
Margins
Efficiency
Dividend
EBITDA margin
23.6%
Gross margin
71.9%
Net margin
12.6%
Operating margin
12.6%
Return on assets
3.7%
Return on equity
8.9%
Return on invested capital
7.1%
Return on capital employed
4.7%
Return on sales
12.6%
Dividend yield
6.89%
DPS
$1.69
Payout ratio
119%
PFE stock price
How has the Pfizer stock price performed over time
Intraday
-3.16%
1 week
-3.95%
1 month
-7.15%
1 year
-11.47%
YTD
-7.5%
QTD
-3.16%
Financial performance
How have Pfizer's revenue and profit performed over time
Revenue
$63.63B
Gross profit
$45.78B
Operating income
$8.02B
Net income
$8.03B
Gross margin
71.9%
Net margin
12.6%
The operating income has soared by 106% from the previous quarter
The company's operating margin has surged by 94% QoQ
Pfizer's net income has surged by 89% QoQ
PFE's net margin has soared by 80% from the previous quarter
Growth
What is Pfizer's growth rate over time
Valuation
What is Pfizer stock price valuation
P/E
17.28
P/B
1.58
P/S
2.18
EV/EBIT
25.29
EV/EBITDA
13.48
EV/Sales
3.18
Pfizer's EPS has soared by 87% from the previous quarter
The price to earnings (P/E) is 11% lower than the 5-year quarterly average of 19.5
PFE's P/B is 41% below its 5-year quarterly average of 2.7 and 12% below its last 4 quarters average of 1.8
Pfizer's equity has decreased by 4.4% QoQ
PFE's P/S is 36% below its 5-year quarterly average of 3.4 and 19% below its last 4 quarters average of 2.7
Pfizer's revenue has increased by 7% YoY and by 5% QoQ
Efficiency
How efficient is Pfizer business performance
The company's return on invested capital has surged by 109% QoQ
Pfizer's ROS has soared by 97% from the previous quarter
Pfizer's ROA has soared by 95% from the previous quarter
The ROE has soared by 89% QoQ
Dividends
What is PFE's dividend history
DPS
$1.69
Dividend yield
6.89%
Payout ratio
119%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Pfizer financials performed over time
PFE's total assets is 71% greater than its total liabilities
The quick ratio has grown by 45% YoY and by 32% from the previous quarter
The current ratio has grown by 29% YoY and by 17% from the previous quarter
PFE's debt is 27% less than its equity
The debt to equity has contracted by 10% YoY
PFE's debt is down by 10% YoY and by 4.9% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.